Literature DB >> 10589404

Pelvic actinomycosis. Is long-term antibiotic therapy necessary?

J Atad1, M Hallak, A Sharon, R Kitzes, Y Kelner, H Abramovici.   

Abstract

OBJECTIVE: To describe 11 cases of actinomycosis and analyze whether long-term antibiotic use in necessary. STUDY
DESIGN: Analysis of 11 cases of pelvic actinomycosis diagnosed and treated during the last nine years. Four patients had an intrauterine device (IUD) for 6-20 years, three patients had an IUD for 3-5 years, and four patients had no known etiology. In most patients the symptoms lasted from several days to one month. The actinomycotic lesions involved one or both ovaries in all 11 cases. In five patients the lesion extended to other areas, such as the uterus, omentum, parametrium, pelvic walls, colon, bladder, cul-de-sac and gallbladder.
RESULTS: All patients underwent surgery that included removal of the lesions with the ipsilateral or both adnexa and, in specific cases, with extension of the lesions, hysterectomy, omentectomy, hemicolectomy and cholecystectomy. Confirmation of the diagnosis of actinomycosis was done by histology in all cases, and antibiotic treatment usually began 1-14 days after surgery. The drug of choice was penicillin. The duration of treatment was 12 months in 6 patients, 6 months in 3 and < or = 3 months in two. All patients were alive and well after two to nine years of follow-up.
CONCLUSION: In contrast to actinomycosis at other sites, where the literature recommends antibiotic therapy for 6-12 months, pelvic actinomycosis could be a limited disease. We propose that in cases of pelvic actinomycosis where the abscess can be completely removed surgically, a shorter period of antibiotic therapy can be effective.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10589404

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  9 in total

1.  Abdominal actinomycosis mimicking acute appendicitis.

Authors:  Erdal Karagulle; Hale Turan; Emin Turk; Halil Kiyici; Erkan Yildirim; Gokhan Moray
Journal:  Can J Surg       Date:  2008-10       Impact factor: 2.089

2.  Clinical features of abdominal actinomycosis: a 15-year experience of a single institute.

Authors:  Hye Young Sung; In Seok Lee; Sang Il Kim; Seung Eun Jung; Sang Woo Kim; Su Young Kim; Mun Kyung Chung; Won Chul Kim; Seong Tack Oh; Won Kyung Kang
Journal:  J Korean Med Sci       Date:  2011-06-20       Impact factor: 2.153

3.  Pseudo-colonic carcinoma caused by abdominal actinomycosis: report of two cases.

Authors:  Chau-Jiunn Huang; Tsung-Jen Huang; Jan-Sing Hsieh
Journal:  Int J Colorectal Dis       Date:  2003-12-20       Impact factor: 2.571

4.  Identification by 16S rRNA gene sequencing of an Actinomyces hongkongensis isolate recovered from a patient with pelvic actinomycosis.

Authors:  A N Flynn; C A Lyndon; D L Church
Journal:  J Clin Microbiol       Date:  2013-05-22       Impact factor: 5.948

Review 5.  Microbiological and Clinical Aspects of Cervicofacial Actinomyces Infections: An Overview.

Authors:  Márió Gajdács; Edit Urbán; Gabriella Terhes
Journal:  Dent J (Basel)       Date:  2019-09-01

Review 6.  Clinical features of abdominopelvic actinomycosis: report of twenty cases and literature review.

Authors:  Myung-Min Choi; Jeong Heum Baek; Jeong Heum Beak; Jung Nam Lee; Sanghui Park; Won-Suk Lee
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

7.  Abdominal actinomycosis presenting as appendicitis: two case reports and review.

Authors:  Ken Liu; David Joseph; Ken Lai; James Kench; Meng Chong Ngu
Journal:  J Surg Case Rep       Date:  2016-05-03

Review 8.  Actinomyces and Alimentary Tract Diseases: A Review of Its Biological Functions and Pathology.

Authors:  Jun Li; Ying Li; Yu Zhou; Changzheng Wang; Benyan Wu; Jun Wan
Journal:  Biomed Res Int       Date:  2018-08-26       Impact factor: 3.411

Review 9.  Abdominal actinomycosis mimicking a transverse colon malignancy: a case report and review of the literature.

Authors:  Gnanaselvam Pamathy; Umesh Jayarajah; Dayal Sathyajith Gamlaksha; Roshana Constantine; Anura S K Banagala
Journal:  J Med Case Rep       Date:  2021-05-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.